Natixis’s Oak Street Health, Inc. OSH Stock Holding History

Natixis’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-350,246	Closed	-$13.5M	–	1189
2023 Q1	$13.5M	Buy	+350,246	New	+$11.3M	0.12%	154
2022 Q3	–	Sell	-142,000	Closed	-$2.33M	–	1204
2022 Q2	$2.33M	Buy	+142,000	New	+$2.76M	0.01%	631
2022 Q1	–	Sell	-11,530	Closed	-$382K	–	1372
2021 Q4	$382K	Buy	+11,530	New	+$436K	﹤0.01%	1081
2021 Q3	–	Sell	-4,119	Closed	-$241K	–	1295
2021 Q2	$241K	Buy	+4,119	New	+$245K	﹤0.01%	803

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Natixis's OSH Position: Q2 2023 in Review

Natixis sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 350,246 shares — an estimated $13.5M sold.

Natixis first reported a position in OSH in Q2 2021 and held it in 4 quarters. The position peaked at $13.5M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Natixis reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Natixis sold 350,246 Oak Street Health, Inc. shares in Q2 2023, an estimated $13.5M.
Natixis first reported a position in Oak Street Health, Inc. in Q2 2021 and held it in 4 quarters.
Natixis's Oak Street Health, Inc. position peaked at $13.5M in Q1 2023.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Natixis's 13F filing for Q2 2023, filed 11 Aug 2023.